Visiongain Publishes Diaphragm Pump Market Report 2020-2030

03 August 2020
Pharma

Visiongain has launched a new pharma report Diaphragm Pump Market Report 2020-2030: Prospects by Operation (Single Acting, Double Acting), Mechanism (Air Operated, Electrically Operated), End Use (Water & Wastewater, Oil & Gas, Chemical & Petrochemical, Pharmaceutical, Food & Beverages), and Geography.

The global diaphragm pump Market is projected to grow at a lucrative CAGR of ~xx% and anticipated to surpass USD xx billion by 2030.

A diaphragm pump or membrane pump is a type of positive displacement pump that pumps fluid using a sequence of diaphragm and valve reciprocating action. Diaphragm pumps are composed of a diaphragm, driving mechanism, two valves and a cavity for displacement. Such pumps are designed to handle different ranges of pressure and varying flow rates. The pump's internal layer consists of raw materials such as polytetrafluoroethylene (PTFE) or Teflon. The emergence of the market for diaphragm pumps also addressed the need for safe disposal of industrial effluents.

Technological advances have resulted in many compact diaphragm pumps being developed that are relatively simpler in design. This has resulted in an increase in diaphragm pump adoption in many industries, resulting in a steady growth of the market for diaphragm pumps during the forecast period. In addition, diaphragm pump features such as adjustable flow control, relatively lower maintenance costs and relatively lower downtime tend to make diaphragm pumps suitable for a wide range of applications.

Diaphragm pumps are well suited for transporting toxic and corrosive fluids without leakage in many offshore drilling applications, this tends to promote growth in the market for diaphragm pumps during the forecast period. It is expected that the introduction of air-operated double diaphragm pumps to transport liquids containing large solids without the use of electricity will drive the growth of the market for diaphragm pumps.

Increased investment in water treatment facilities and oil and gas industries are projected to be the key drivers of the global market over the estimated period. Increasing demand for freshwater has accelerated market growth in emerging regions as a result of the growing population along with rapid industrialization and urbanization.

Using chemical and physical separation processes, water treatment helps remove toxic elements from the water. Diaphragm pumps are capable of handling highly viscous fluids, solid particle liquids, hazardous materials or liquids mainly used in water treatment industries. They are therefore used in applications such as bulk transfer, refining, mud transfer of circulation drilling, waste processing, refueling, loading and unloading, and injection of the wellhead.

The global diaphragm market is dominated by the Asia Pacific region owing to rapid urbanization, 100% FDI, growing demand for fuel energy, growing awareness for clean drinking water, and growing construction activities in the region. The emerging economies like India, China, and Japan are anticipated to offer lucrative opportunities for revenue generation for the players operating in the diaphragm market owing to growing manufacturing industries, growing penetration of major players, and growing government investments among other contributing factors are anticipated to fuel market growth further.

Some of the major players operating in this industry are Dover Corporation, Flowserve, Grundfos Holding A/S, Idex Corporation, Ingersoll Rand, LEWA Group, Raco Inc., SPX Flow, Tapflo, Verder Group, Xylem Inc., Yamada Corporation, Grundfos Pumps Corp., Alltech Dosieranlagen GmbH, Depamu Pumps Technology Co., Ltd., Seko S.p.a among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

Read

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

Read

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

Read

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever